IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-39

  1. 244 Posts.
    lightbulb Created with Sketch. 56
    The average reduction in AHI calculated across low, mid, and high-dose IHL-42X has met our expectations for what would constitute a valuable product for the treatment of obstructive sleep apnoea.

    BOOOOM !
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.